Anúncio
Anúncio

ARDX

ARDX logo

Ardelyx, Inc.

7.00
USD
Patrocinado
+1.17
+19.98%
08 de jan., 15:59 UTC -5
Encerrado
exchange

Pós-Mercado

7.15

+0.15
+2.17%

Relatórios de Lucros ARDX

Rácio de surpresa positiva

ARDX separação 26 de 40 últimas estimativas.

65%

Próximo Relatório

Data do Próximo Relatório
18 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$121.79M
/
$0.01
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+10.39%
/
--
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+4.87%
/
-50.00%

Ardelyx, Inc. earnings per share and revenue

On 30 de out. de 2025, ARDX reported earnings of 0.00 USD per share (EPS) for Q3 25, beating the estimate of -0.05 USD, resulting in a 100.00% surprise. Revenue reached 110.33 milhão, compared to an expected 103.54 milhão, with a 6.55% difference. The market reacted with a +20.96% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 13 analistas forecast an EPS of 0.01 USD, with revenue projected to reach 121.79 milhão USD, implying an -- of --% EPS, and aumentar of 10.39% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Citius Pharmaceuticals Inc. Common
Report Date
26 de dez. de 2025 Para Q4 25
Estimativa
-$0.49
Real
-
Surpresa
-
FAQ
For Q3 2025, Ardelyx, Inc. reported EPS of $0.00, beating estimates by 100%, and revenue of $110.33M, 6.55% above expectations.
The stock price moved up 20.96%, changed from $5.01 before the earnings release to $6.06 the day after.
The next earning report is scheduled for 18 de fev. de 2026.
Based on 13 analistas, Ardelyx, Inc. is expected to report EPS of $0.01 and revenue of $121.79M for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio